@article{c6b9a05011eb41d0a0f23eb93c4dc6a6,
title = "Author Correction: Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial (Nature Medicine, (2022), 28, 10, (2155-2161), 10.1038/s41591-022-01962-5)",
abstract = "Correction to: Nature Medicine. Published online 12 September 2022. In the version of this article initially published, the first sentence of the Fig. 4a caption (now reading “The expression of different NK cell surface receptors was determined by scRNA-seq”) was incorrectly preceded by the text “Association between gene expression in NK cells and the percentage of viable tumor cells,” which has now been removed from the HTML and PDF versions of the article.",
author = "{LCMC study investigators} and Chaft, {Jamie E.} and Filiz Oezkan and Kris, {Mark G.} and Bunn, {Paul A.} and Wistuba, {Ignacio I.} and Kwiatkowski, {David J.} and Owen, {Dwight H.} and Yan Tang and Johnson, {Bruce E.} and Lee, {Jay M.} and Gerard Lozanski and Maciej Pietrzak and Michal Seweryn and Byun, {Woo Yul} and Katja Schulze and Alan Nicholas and Ann Johnson and Jessica Grindheim and Stephanie Hilz and Shames, {David S.} and Chris Rivard and Eric Toloza and Haura, {Eric B.} and McNamee, {Ciaran J.} and Patterson, {G. Alexander} and Waqar, {Saiama N.} and Rusch, {Valerie W.} and Carbone, {David P.} and Waqar, {Saiama N.} and Elaine Shum and Misako Nagasaka and Marianna Koczywas and Garon, {Edward B.} and Finley, {David J.} and Camidge, {David R.} and Carlisle, {Jennifer W.} and Blasberg, {Justin D.}",
note = "Publisher Copyright: {\textcopyright} 2023, The Author(s).",
year = "2024",
month = jan,
doi = "10.1038/s41591-023-02627-7",
language = "English (US)",
volume = "30",
pages = "303",
journal = "Nature medicine",
issn = "1078-8956",
publisher = "Nature Publishing Group",
number = "1",
}